Literature DB >> 11159835

Regulation of metallothionein II messenger ribonucleic acid measures exogenous estrogen receptor-beta activity in SAOS-2 and LNCaPLN3 cells.

H Harris1, R Henderson, R Bhat, B Komm.   

Abstract

Estrogen receptor-beta (ERbeta) is a recently discovered member of the steroid hormone superfamily. Because its distribution is distinct from that of the classical estrogen receptor, and it is expressed in several nonclassical estrogen target tissues (e.g. prostate and bladder), its role in mediating the action of estrogen is unclear. One approach to elucidating the function of this receptor is to identify genes that it regulates. Using differential display, we profiled the messenger RNAs regulated by 17beta-estradiol in SAOS-2 and LNCaPLN3 cells overexpressing ERbeta. Follow-up studies used cells expressing either ERalpha or ERbeta. One gene, metallothionein II, was regulated by both receptor subtypes in LNCaPLN3 cells, but only by ERbeta in SAOS-2 cells. Because cycloheximide blocks this response, induction is probably mediated through regulation of at least one other protein. Identification of endogenous genes that are regulated differentially by ERalpha and ERbeta will be valuable tools in elucidating the function of ERbeta and the mechanisms by which these two receptors regulate transcription.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159835     DOI: 10.1210/endo.142.2.7952

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  ER beta inhibits proliferation and invasion of breast cancer cells.

Authors:  G Lazennec; D Bresson; A Lucas; C Chauveau; F Vignon
Journal:  Endocrinology       Date:  2001-09       Impact factor: 4.736

2.  Steroid receptor status, proliferation and metallothionein expression in primary invasive ductal breast cancers.

Authors:  Paweł Surowiak; Piotr Paluchowski; Teresa Wysocka; Andrzej Wojnar; Maciej Zabel
Journal:  Pathol Oncol Res       Date:  2004-12-27       Impact factor: 3.201

3.  Estrogen receptor signaling protects against immune suppression by UV radiation exposure.

Authors:  Sitarina Widyarini; Diane Domanski; Nicole Painter; Vivienne E Reeve
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

4.  Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity.

Authors:  Christopher C Chadwick; Susan Chippari; Edward Matelan; Lisa Borges-Marcucci; Amy M Eckert; James C Keith; Leo M Albert; Yelena Leathurby; Heather A Harris; Ramesh A Bhat; Mark Ashwell; Eugene Trybulski; Richard C Winneker; Steven J Adelman; Robert J Steffan; Douglas C Harnish
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

Review 5.  Loss of ERbeta expression as a common step in estrogen-dependent tumor progression.

Authors:  A Bardin; N Boulle; G Lazennec; F Vignon; P Pujol
Journal:  Endocr Relat Cancer       Date:  2004-09       Impact factor: 5.678

6.  Estrogen modulates developmentally regulated gene expression in the fetal baboon liver.

Authors:  Miriam D Rosenthal; Eugene D Albrecht; Gerald J Pepe
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.